<DOC>
	<DOCNO>NCT02765919</DOCNO>
	<brief_summary>The purpose study compare two diffrent brachytherapy treatment option locally advance carcinoma uterine cervix . Brachytherapy two fraction 9 Gy effective locoregional control convenient term cost time 7 Gy brachytherapy 3 fraction management locally advance carcinoma cervix .</brief_summary>
	<brief_title>A Randomised Controlled Trial Between Two Different HDR Brachytherapy Schedule Locally Advanced Carcinoma Uterine Cervix</brief_title>
	<detailed_description>Cervical cancer second common cancer among woman worldwide commonest form gynecolgic malignancy Bangladesh.Radiotherapy form external beam radiotherapy combine intracavitary Brachytherapy accept definitive mode treatment.Limiting number high dose rate ( HDR ) Brachytherapy potential benefit improve patient compliance reduce treatment cost duration.The aim study compare treatment outcome acute complication follow treatment 9 Gray ( Gy ) two fraction brachytherapy standard EBRT locally advance carcinoma cervix . EBRT deliver cobalt 60 teletherapy unit prescribe dose 50 Gy 25 fraction 2 Gy per fraction 5 day week period 5 week concurrent inj . Cisplatin 40 mg/meter square weekly 5 weeks.The patient randomise two arm HDR brachytherapy , either 9Gy 2 fraction 7 Gy 3 fractions.All patient follow per guideline 6 months.The treatment related toxicity measure Common Toxicity Criteria ( Common terminology criterion adverse event v.3.0 ) . All relevant collect data compile master chart statistical analysis result obtain use SPSS 17.The data analyse use Chi square test T test.Significant value decide level 0.05 two tailed test .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<criteria>Locally advanced carcinoma cervix ( stage 2b 4a ) Histopathology squamous cell carcinoma Previous history malignancy Previously treat radiotherapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Carcinoma cervix</keyword>
	<keyword>RCT ( randomise control trial )</keyword>
	<keyword>9 Gray</keyword>
	<keyword>Brachytherapy</keyword>
</DOC>